Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Investigational Urine Test Aids Appendicitis Diagnosis

By HospiMedica International staff writers
Posted on 20 Aug 2009
An experimental pediatric urine test could one day spot appendicitis faster and more accurately than current tests, claims a new study.

Researchers at Children's Hospital Boston (CHB, MA, USA) first examined urine samples from six patients with appendicitis and six without appendicitis. More...
The researchers then identified 32 possible associated biomarkers; to these, they added 25 other markers found in gene studies. The researchers then looked for these 57 potential markers in 67 children with possible appendicitis; among these children, 25 actually did have appendicitis. Tests of performance of the markers were evaluated against the pathologic diagnosis and histologic grade of appendicitis. The researchers eventually identified seven biomarkers linked with appendicitis that exhibited favorable diagnostic performance, including calgranulin A (S100-A8), alpha-1-acid glycoprotein 1 (orosomucoid), and leucine-rich alpha-2-glycoprotein (LRG). LRG especially was enriched in diseased appendices, and its abundance correlated with severity of appendicitis. The study was published ahead of print in the June 23, 2009, online edition of the Annals of Emergency Medicine.

"We have found a protein in the urine that is diagnostic for appendicitis,” said study co-author Hanno Steen, Ph.D., director of the proteomics center at CHB. "This would mean that diagnosis of appendicitis is faster, more reliable and much more cost-efficient.”

Ultrasound and computed tomography (CT) scans are currently used to diagnose appendicitis, yet 3-30% of children have unnecessary appendectomies, while 30-45% of those diagnosed with appendicitis already have a ruptured appendix. In addition, patients can wait hours in the emergency room before they are able to have these tests; the new test could diagnose appendicitis in just 30 minutes and result in fewer unnecessary surgeries. However, the test still needs to be validated in adults.

Related Links:
Children's Hospital Boston



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.